Finished
Assistive Soft Robotic Glove (EsoGLOVE) Intervention for Stroke Patients
NCT05995665 · Alexandra Hospital · Updated 13 July 2026
- What is being tested
- EsoGLOVE; Graded Repetitive Arm Supplementary Program (GRASP)
- For
- Stroke
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 21 years to 90 years. About 61 people. The full rules are on the registry page.
- Where
- Singapore (2 sites)
- When
- Starts or started 11 July 2023, ends 31 Aug 2025. Registered 16 Aug 2023.
- Results
- None posted yet.
In the researchers' words
This proposed research aims to assess the efficacy and feasibility of the EsoGLOVE in the inpatient rehabilitation setting. 1. Understanding the ability of the EsoGLOVE in providing exercise and assisting stroke patients with completing hand functional tasks, eventually improves patients' motor function and neural recovery.2. To generate evidence on this innovative device and further deploy it in clinical practice. A Health Technology Assessment (HTA) will be generated from this study to evaluate the cost-effectiveness of the intervention.
Sites
- Alexandra HospitalSingapore, Singapore
- Jurong Community HospitalSingapore, Singapore